2,459 Axon Enterprise, Inc $AXON Shares Sold by N10 Assets LLC

N10 Assets LLC trimmed its position in Axon Enterprise, Inc (NASDAQ:AXON) by 17.8% during the third quarter, HoldingsChannel.com reports. The firm owned 11,349 shares of the biotechnology company’s stock after selling 2,459 shares during the quarter. Axon Enterprise accounts for approximately 1.8% of N10 Assets LLC’s investment portfolio, making the stock its 23rd biggest holding. N10 Assets LLC’s holdings in Axon Enterprise were worth $4,795,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Keating Financial Advisory Services Inc. bought a new position in shares of Axon Enterprise during the second quarter worth about $31,000. Washington Trust Advisors Inc. raised its position in Axon Enterprise by 1,300.0% in the 2nd quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock valued at $39,000 after buying an additional 65 shares during the last quarter. Wealth Enhancement Trust Services Inc. bought a new stake in Axon Enterprise in the 3rd quarter valued at approximately $33,000. Delos Wealth Advisors LLC acquired a new position in Axon Enterprise during the 2nd quarter worth approximately $45,000. Finally, Owl Creek Wealth Partners LLC boosted its position in Axon Enterprise by 84.8% during the 2nd quarter. Owl Creek Wealth Partners LLC now owns 85 shares of the biotechnology company’s stock worth $48,000 after acquiring an additional 39 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Jeffrey C. Kunins sold 9,605 shares of the business’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the transaction, the insider directly owned 97,761 shares in the company, valued at $61,266,818.70. The trade was a 8.95% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the transaction, the chief executive officer owned 3,118,012 shares in the company, valued at $1,587,036,927.88. This represents a 0.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 47,397 shares of company stock worth $26,722,984. 4.20% of the stock is owned by insiders.

Axon Enterprise Stock Down 2.5%

Shares of NASDAQ AXON traded down $10.24 during trading hours on Wednesday, hitting $403.11. The company had a trading volume of 379,333 shares, compared to its average volume of 1,047,241. The stock has a market capitalization of $32.75 billion, a P/E ratio of 167.16, a price-to-earnings-growth ratio of 7.80 and a beta of 1.44. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $764.02. The firm’s 50 day moving average is $511.34 and its 200-day moving average is $475.41.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.84 by $0.04. The business had revenue of $904.39 million during the quarter, compared to analysts’ expectations of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm’s revenue was up 35.3% on a year-over-year basis. During the same period last year, the business earned $2.12 earnings per share. On average, analysts expect that Axon Enterprise, Inc will post 2.12 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. The Goldman Sachs Group reaffirmed a “buy” rating and set a $715.00 price target on shares of Axon Enterprise in a research note on Thursday, August 6th. Royal Bank Of Canada reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, July 21st. Citigroup reissued a “market outperform” rating on shares of Axon Enterprise in a research report on Thursday, September 17th. Argus increased their target price on shares of Axon Enterprise from $460.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday, September 3rd. Finally, Barclays raised their target price on shares of Axon Enterprise from $523.00 to $688.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $721.57.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and connected systems for public safety and law enforcement agencies. Its product portfolio includes TASER conducted energy weapons, body-worn cameras, in-car cameras and other recording devices designed to support safer interactions, improve accountability and document incidents.

The company also provides cloud-based software for managing digital evidence, reports, records and agency operations. Its Axon platform connects hardware with services such as evidence management, real-time operations, computer-aided dispatch and other workflow tools, enabling agencies to store, organize and share information across their organizations.

Founded in 1993 as AIR TASER by Rick Smith and Tom Smith, the company later operated as TASER International before adopting the name Axon Enterprise in 2017.